Literature DB >> 29778401

High intensity focused ultrasound: The fundamentals, clinical applications and research trends.

I A Shehata Elhelf1, H Albahar2, U Shah3, A Oto4, E Cressman5, M Almekkawy2.   

Abstract

Diagnostic ultrasound has been clinically used for decades. More recently, high intensity focused ultrasound (HIFU) has been developed for therapeutic use as a non-invasive technique for tissue ablation. HIFU is also being investigated for advanced applications at the cellular level. Under guidance by magnetic resonance or ultrasound imaging, HIFU can achieve precise biological effects in tissue with a high safety profile. In this article, we discuss the basic principles, advantages and limitations of HIFU. We will also address the food and drug administration (FDA) approved clinical applications in the United States and highlight active HIFU research with promising clinical outcomes.
Copyright © 2018 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Keywords:  High intensity focused ultrasound (HIFU); Immunomodulation; Interventional oncology; Temperature sensitive liposomes; Thermal ablation

Mesh:

Year:  2018        PMID: 29778401     DOI: 10.1016/j.diii.2018.03.001

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  33 in total

1.  Interaction mechanism between the focused ultrasound and lipid membrane at the molecular level.

Authors:  Viet Hoang Man; Mai Suan Li; Junmei Wang; Philippe Derreumaux; Phuong H Nguyen
Journal:  J Chem Phys       Date:  2019-06-07       Impact factor: 3.488

2.  High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results.

Authors:  Pierpaolo Trimboli; Federico Pelloni; Fabiano Bini; Franco Marinozzi; Luca Giovanella
Journal:  Endocrine       Date:  2019-03-28       Impact factor: 3.633

Review 3.  Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.

Authors:  Jordan B Joiner; Yuliya Pylayeva-Gupta; Paul A Dayton
Journal:  J Immunol       Date:  2020-11-01       Impact factor: 5.422

4.  Temperature-Responsive Hydrophobic Silica Nanoparticle Ultrasound Contrast Agents Directed by Phospholipid Phase Behavior.

Authors:  Nicholas T Blum; Adem Yildirim; Ciara Gyorkos; Dennis Shi; Angela Cai; Rajarshi Chattaraj; Andrew P Goodwin
Journal:  ACS Appl Mater Interfaces       Date:  2019-04-23       Impact factor: 9.229

5.  US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy.

Authors:  Fujie Jiang; Lu Wang; Yu Tang; Yaotai Wang; Ningshan Li; Disen Wang; Zhong Zhang; Li Lin; Yan Du; Xia Ou; Jianzhong Zou
Journal:  Int J Nanomedicine       Date:  2022-07-04

Review 6.  What scans we will read: imaging instrumentation trends in clinical oncology.

Authors:  Thomas Beyer; Luc Bidaut; John Dickson; Marc Kachelriess; Fabian Kiessling; Rainer Leitgeb; Jingfei Ma; Lalith Kumar Shiyam Sundar; Benjamin Theek; Osama Mawlawi
Journal:  Cancer Imaging       Date:  2020-06-09       Impact factor: 3.909

7.  Multiplexing Focused Ultrasound Stimulation with Fluorescence Microscopy.

Authors:  Jerome J Lacroix; Alper D Ozkan
Journal:  J Vis Exp       Date:  2019-01-07       Impact factor: 1.355

8.  Ultrasound responsive mesoporous silica nanoparticles for biomedical applications.

Authors:  Miguel Manzano; María Vallet-Regí
Journal:  Chem Commun (Camb)       Date:  2019-02-28       Impact factor: 6.222

9.  Bubble Cloud Behavior and Ablation Capacity for Histotripsy Generated from Intrinsic or Artificial Cavitation Nuclei.

Authors:  Connor Edsall; Zerin Mahzabin Khan; Lauren Mancia; Sarah Hall; Waleed Mustafa; Eric Johnsen; Alexander L Klibanov; Yasemin Yuksel Durmaz; Eli Vlaisavljevich
Journal:  Ultrasound Med Biol       Date:  2020-12-10       Impact factor: 2.998

10.  Dual-Frequency Intravascular Sonothrombolysis: An In Vitro Study.

Authors:  Huaiyu Wu; Leela D Goel; Howuk Kim; Bohua Zhang; Jinwook Kim; Paul A Dayton; Zhen Xu; Xiaoning Jiang
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-11-23       Impact factor: 2.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.